Full Text View
Tabular View
No Study Results Posted
Related Studies
Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation
This study has been completed.
Study NCT00621894   Information provided by Ligand Pharmaceuticals
First Received: February 12, 2008   Last Updated: July 29, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Immune Thrombocytopenic Purpura
Additional conditions recognized in this trial
Purpura
Purpura, Thrombocytopenic
More general conditions related to this trial
Blood Coagulation Disorders
Blood Platelet Disorders
Hematologic Diseases
Immune System Diseases
Signs and Symptoms
Skin Manifestations
Thrombocytopenia
Interventions listed in this trial
LGD-4665
Placebo
Sponsors listed in this trial
Ligand Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services